Trial · NCT01547104
Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
NCT01547104, Phase 4, Unknown, Marcus Borchert
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus. Trials, record NCT01547104. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01547104
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
- NCT number
- NCT01547104
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Marcus Borchert
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Linagliptin, Glimepiride
- First posted
- 2012-03-07
- Last updated
- 2012-04-11
- Other registries' IDs
- eudract:2012-000179-17
Source ClinicalTrials.gov
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Postprandial increase in intact Proinsulin levels (Peak, AUC) | 30, 60, 90, 120, 150, 180, 210, 240, 270 300 mins post test meal procedure, 3 times within 12 weeks treatment | |
| Primary | Postprandial Proinsulin/Insulin Ratio | after 12 weeks treatment | |
| Primary | Fasting intact Proinsulin levels | after 12 weeks treatment | |
| Primary | Fasting Proinsulin/Insulin Ratio | after 12 weeks treatment | |
| Primary | Fasting Blood Glucose | after 12 weeks treatment | |
| Primary | Postprandial Blood Glucose Excursions (Peak; AUC) | 30, 60, 90, 120, 150, 180, 210, 240, 270 300 mins post test meal procedure, 3 times within 12 weeks treatment | |
| Primary | Fasting Lipids | after 12 weeks treatment | |
| Primary | Postprandial Lipids | after 12 weeks treatment | |
| Primary | Fasting Erythrocyte Flexibility | after 12 weeks treatment | |
| Primary | Postprandial Erythrocyte Flexibility | after 12 weeks treatment |
1 to 10 of 23Source ClinicalTrials.gov
See all 23 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01547104
GET https://conductscience.org/api/trials/v1/NCT01547104/registered?page=2